2-[(6-chloro-3-pyridinyl)sulfonylamino]-N-[(4-methylphenyl)methyl]benzamide : no description available [CHeBI]
Assay ID | Title | Year | Journal | Article |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X | |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X | |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
3-aminobenzamide | | benzamides; substituted aniline | EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dan 2163 | | aromatic amide; aromatic amine; benzamides; pyrrolidines; sulfone | environmental contaminant; second generation antipsychotic; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bromopride | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ci 994 | | acetamides; benzamides; substituted aniline | antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cisapride | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hexyloxybenzamide | | aromatic ether; benzamides | antifungal agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
itopride | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
labetalol | | benzamides; benzenes; phenols; primary carboxamide; salicylamides; secondary alcohol; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lorglumide | | benzamides; dicarboxylic acid monoamide; dichlorobenzene; glutamic acid derivative | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide | | benzamides; hydroxamic acid; secondary carboxamide; tertiary amino compound | antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
metoclopramide | | benzamides; monochlorobenzenes; substituted aniline; tertiary amino compound | antiemetic; dopaminergic antagonist; environmental contaminant; gastrointestinal drug; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
moclobemide | | benzamides; monochlorobenzenes; morpholines | antidepressant; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
entinostat | | benzamides; carbamate ester; primary amino compound; pyridines; substituted aniline | antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deet | | benzamides; monocarboxylic acid amide | environmental contaminant; insect repellent; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acecainide | | acetamides; benzamides | anti-arrhythmia drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nemonapride | | benzamides; monochlorobenzenes; monomethoxybenzene; N-alkylpyrrolidine; secondary amino compound; secondary carboxamide; substituted aniline | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
niclosamide | | benzamides; C-nitro compound; monochlorobenzenes; salicylanilides; secondary carboxamide | anthelminthic drug; anticoronaviral agent; antiparasitic agent; apoptosis inducer; molluscicide; piscicide; STAT3 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
picotamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
procainamide | | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
procarbazine | | benzamides; hydrazines | antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
proglumetacin | | aromatic ether; benzamides; carboxylic ester; monochlorobenzenes; N-acylindole; N-alkylpiperazine | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; lipoxygenase inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
proglumide | | benzamides; dicarboxylic acid monoamide; glutamine derivative; racemate | anti-ulcer drug; cholecystokinin antagonist; cholinergic antagonist; delta-opioid receptor agonist; drug metabolite; gastrointestinal drug; opioid analgesic; xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
imatinib | | aromatic amine; benzamides; N-methylpiperazine; pyridines; pyrimidines | antineoplastic agent; apoptosis inducer; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sulpiride | | benzamides; N-alkylpyrrolidine; sulfonamide | antidepressant; antiemetic; antipsychotic agent; dopaminergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tiapride | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trimethobenzamide | | benzamides; tertiary amino compound | antiemetic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
troxipide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zm 336372 | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
iodohippuric acid | | benzamides; N-acylglycine; organoiodine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzoylarginine-2-naphthylamide | | arginine derivative; benzamides; N-(2-naphthyl)carboxamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(benzoylamino)-2-hydroxybenzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ameltolide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
antimycin a | | benzamides; formamides; macrodiolide; phenols | antifungal agent; mitochondrial respiratory-chain inhibitor; piscicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rebemide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,6-dichlorobenzamide | | benzamides; dichlorobenzene | herbicide; marine xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluorophene | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-toluanilide | | benzamides; benzanilide fungicide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-bromo-N-phenylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xipamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
capobenic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pronamide | | benzamides; dichlorobenzene; terminal acetylenic compound | agrochemical; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clanobutin | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nitazoxanide | | benzamides; carboxylic ester | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Flamprop | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(dimethylamino)phenyl]-3,4,5-trimethoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
endralazine | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flutolanil | | (trifluoromethyl)benzenes; aromatic ether; benzamides; benzanilide fungicide | antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
encainide | | benzamides; piperidines | anti-arrhythmia drug; sodium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nelfinavir | | aryl sulfide; benzamides; organic heterobicyclic compound; phenols; secondary alcohol; tertiary amino compound | antineoplastic agent; HIV protease inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-benzoylpiperidine | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pancopride | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
octylonium | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
parsalmide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoxaben | | benzamides; isoxazoles | cellulose synthesis inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-aminobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-Methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzoyltyrosine ethyl ester | | benzamides; ethyl ester; L-tyrosine derivative; phenols | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
salifungin | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-benzoyl-l-arginine | | benzamides; N-acyl-L-arginine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gr 127935 | | 1,2,4-oxadiazole; benzamides; N-alkylpiperazine; N-arylpiperazine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zacopride | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mozavaptan | | benzamides | aquaretic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mosapride | | aromatic ether; benzamides; monochlorobenzenes; monofluorobenzenes; morpholines; secondary carboxamide; substituted aniline; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zoxamide | | alpha-chloroketone; benzamides; dichlorobenzene | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
procainamide 4-hydroxylamine | | benzamides; hydroxylamines | drug metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ly 188544 | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gr 55562 | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-(2,6-dimethylphenyl)-4-(((diethylamino)acetyl)amino)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tariquidar | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-benzoyltyrosine | | benzamides; N-acyl-L-tyrosine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rp 73401 | | aromatic ether; benzamides; chloropyridine; monocarboxylic acid amide | anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; phosphodiesterase IV inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
brovanexine | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aminopotentidine | | aromatic ether; benzamides; guanidines; nitrile; piperidines; substituted aniline | H2-receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
asperphenamate | | benzamides; carboxylic ester; L-phenylalanine derivative | antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-fluorophenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzoylphenylalanine | | benzamides; N-acyl-amino acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxy-N-[2-(methylthio)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-fluorobenzoylamino)benzoic acid methyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xv 638 | | 1,3-thiazoles; benzamides; diazepanone; diol; secondary alcohol; secondary carboxamide; ureas | HIV protease inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
roflumilast | | aromatic ether; benzamides; chloropyridine; cyclopropanes; organofluorine compound | anti-asthmatic drug; phosphodiesterase IV inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(3-benzamidophenoxy)acetic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ck-0944666 | | benzamides; indoles; organofluorine compound | actin polymerisation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gw9662 | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(1-cyclohexenyl)ethyl]-4-(4-morpholinylmethyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxy-N-[6-(1-oxobutylamino)-3-pyridinyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-chloro-2-[(2,4-dimethoxyanilino)-oxomethyl]phenyl]-2-furancarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[3-[3-(5-methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-phenylmethanone | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methyl-N-[2-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(2-ethyl-5-tetrazolyl)phenyl]-3-(1-tetrazolyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(2-ethyl-5-tetrazolyl)phenyl]-4-(1-tetrazolyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2,5-diethoxy-4-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]phenyl]-2-furancarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(2,4-difluorophenyl)-[3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]methanone | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-ethoxy-N-[4-(4-morpholinylsulfonyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methyl-N-(2-methyl-5-tetrazolyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2,5-dimethoxy-4-[[2-(4-morpholinyl)-1-oxoethyl]amino]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-fluorophenyl)-4-(2-oxolanylmethylsulfamoyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azidopine | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxy-N1,N3-bis(3-pyridinyl)benzene-1,3-dicarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,3,4,5,6-pentafluoro-N-(phenylmethyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(1,1-dioxo-3-thiolanyl)-N-(thiophen-2-ylmethyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-methoxyphenyl)-2-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[(4-acetyloxy-3-methoxyphenyl)-oxomethyl]amino]-5-hydroxybenzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-acetamidophenyl)-4-methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-acetamidophenyl)-3-chlorobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxy-N-(5-methyl-3-isoxazolyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-tert-butyl-N-[4-(4-morpholinyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-fluorophenyl)-4-phenylmethoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methyl-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methyl-N-[4-(4-morpholinyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxy-N-(3-pyridinylmethyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxy-N-(2-pyridinyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(4-oxo-3,1-benzoxazin-2-yl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(4-pyrimidinylthio)methyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-acetamidophenyl)-2-bromobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(5-acetyl-4-methyl-2-thiazolyl)-4-tert-butylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(5-acetyl-4-methyl-2-thiazolyl)-2-methylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-ethoxy-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3,4-dimethoxyphenyl)-4-methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-[(4-methylanilino)-oxomethyl]phenyl]-3-pyridinecarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(2,5-dimethyl-1-pyrrolyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-chloro-3-(trifluoromethyl)phenyl]-3-methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-acetamidophenyl)-2-chlorobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-ethoxy-N-(2-thiazolyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-bromo-N-(3-methoxyphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2,4-difluorophenyl)-3-methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[(4-acetyloxy-3-methoxyphenyl)-oxomethyl]amino]benzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetic acid [4-[(4-hydroxyanilino)-oxomethyl]-2-methoxyphenyl] ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-benzamido-2-chlorophenyl)-2-furancarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(hydroxymethyl)-N-(phenylmethyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[(3-methylphenyl)-oxomethyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-chloro-4-methyl-N-[4-(4-methyl-1-piperazinyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-ethoxy-N-(2-hydroxyphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[[(3-chloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxy-N-(4-methylphenyl)-4-(methylthio)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[[(4-methoxyphenyl)-oxomethyl]amino]-2-thiophenecarboxylic acid methyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxy-3-methyl-N-[4-(4-morpholinylmethyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-anilinophenyl)-3,4-dimethoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-4-methylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[[(6-methyl-4-pyrimidinyl)thio]methyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-acetamidophenyl)-2-methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-bromo-N-[3-(1-oxopropylamino)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-acetylphenyl)-3-ethoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[(3-bromophenyl)-oxomethyl]amino]-5-hydroxybenzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-azepanyl-[4-[(phenylthio)methyl]phenyl]methanone | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloro-N-[4-(2-imidazo[1,2-a]pyridinyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4,5-triethoxy-N-(1H-1,2,4-triazol-5-yl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[[[3-(4-methoxyphenyl)phenyl]-oxomethyl]amino]benzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(4-ethoxyphenoxy)methyl]-N,N-diethylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-tert-butyl-N-(4-methyl-3-nitrophenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-methoxyphenyl)-4-[(2-methyl-1-oxopropyl)amino]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-3,4,5-trimethoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloro-3-[[(2-methyl-3-nitrophenyl)-oxomethyl]amino]benzoic acid methyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-nitrobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-methoxyphenyl)-2-(methylthio)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-[[(3,5-dimethoxyphenyl)-oxomethyl]amino]phenyl]carbamic acid ethyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-dimethyl-N-[4-(1-pyrrolidinyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(7-bromo-3,4-dihydro-2H-1,5-benzodioxepin-8-yl)-3-methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-chloro-N-(2-furanylmethyl)-2-[[(4-methoxyphenyl)-oxomethyl]amino]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(2-bromophenoxy)methyl]-N-[4-[(3,5-dimethyl-1-pyrazolyl)methyl]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-bromo-5-ethoxy-N-(4-fluorophenyl)-4-methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-chloro-N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-5-(1,2,4-triazol-4-yl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[[(3,5-dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[4-[[(3,4-dimethylphenyl)-oxomethyl]amino]phenoxy]phthalic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-ethyl-2-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]-3-thiophenecarboxylic acid ethyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-bromo-N-[3-(1-oxobutylamino)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-chloro-N-[3-nitro-5-(2-pyridinylthio)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-chloro-2-[(2-ethoxyanilino)-oxomethyl]phenyl]-2-furancarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[[3-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]benzoic acid ethyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dimethoxy-N-[4-[oxo(1-piperidinyl)methyl]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-fluoro-N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-benzamido-3-methylphenyl)-1,3-benzodioxole-5-carboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-benzamidophenyl)-1,3-benzodioxole-5-carboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2,2-dichloro-1-(4-chlorophenyl)sulfonylethenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[[3-[2-(4-methylphenyl)sulfonylethylthio]phenyl]-oxomethyl]amino]benzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloro-N-[3-chloro-4-(4-morpholinyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-methoxyphenyl)-4-(1-oxopropylamino)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-4-methylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[2-methoxy-4-(methylthio)phenyl]-[4-(phenylmethyl)-1-piperidinyl]methanone | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2,5-diethoxy-4-[[(3-methoxyanilino)-sulfanylidenemethyl]amino]phenyl]-4-methylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[[anilino(sulfanylidene)methyl]amino]-2,5-diethoxyphenyl]-4-methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[[anilino(sulfanylidene)methyl]amino]-2,5-diethoxyphenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chloro-3-methylphenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(3-chlorophenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chloro-2-methylphenoxy)acetic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(1,3-dioxo-2-isoindolyl)propanoic acid [4-[(4-methylanilino)-oxomethyl]phenyl] ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-bromo-2-furancarboxylic acid (3-benzamidophenyl) ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(4-ethoxyphenyl)-[4-[(4-ethoxyphenyl)-oxomethyl]-1,4-diazepan-1-yl]methanone | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[4-[(2-bromophenoxy)methyl]phenyl]-(1-piperidinyl)methanone | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(4-bromophenoxy)methyl]-N-(5-methyl-3-isoxazolyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methyl-N-[4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[methyl(phenyl)sulfamoyl]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[(N-methylanilino)-oxomethyl]phenyl]-2-furancarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[[[3-(1-azepanylsulfonyl)-4-chlorophenyl]-oxomethyl]amino]benzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[2-nitro-4-(trifluoromethyl)phenoxy]-N-phenylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloro-N-[2-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[[(4-methoxyphenyl)-oxomethyl]amino]methyl]-5-phenyl-3-furancarboxylic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3,5-dichlorophenyl)-2-(methanesulfonamido)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(5-chloro-2-methylphenyl)-4-[(4-chloro-1-pyrazolyl)methyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[2-[(4-chlorophenyl)thio]-1-oxoethyl]amino]-N-(4-methoxyphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxy-N-[2-(4-morpholinyl)phenyl]-3-nitrobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-bromo-N-[4-(4-methyl-1-piperazinyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[[[(5-bromo-2-furanyl)-oxomethyl]hydrazo]-oxomethyl]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-bromo-2-methoxy-3-methyl-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxy-N-[4-[[(1-oxopropylamino)-sulfanylidenemethyl]amino]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[(3,5-dimethoxyphenyl)-oxomethyl]amino]-4,5-dimethoxybenzoic acid methyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4,5-trimethoxy-N-(2-phenylphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-ethoxy-N-[3-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[[3-methyl-4-[[2-(3-nitrophenoxy)-1-oxoethyl]amino]phenyl]-oxomethyl]amino]benzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methyl-N-[2-methyl-1,3-bis[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]propan-2-yl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[4-[(2,4-dichlorophenoxy)methyl]phenyl]-(4-methyl-1-piperazinyl)methanone | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-furanylmethyl)-2-[[[2-[(4-methylphenyl)sulfonyl-(phenylmethyl)amino]phenyl]-oxomethyl]amino]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-cyanophenyl)thio]-N-[4-[dimethylamino(oxo)methyl]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-furanylmethyl)-2-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-[[(4-nitrophenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(3-benzamidoanilino)-sulfanylidenemethyl]-2-thiophenecarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-chloro-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3,4-dimethoxyphenyl)-4-[(4-phenyl-1-piperazinyl)methyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-cyano-N-methyl-N-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-tert-butyl-N-[2,5-dimethoxy-4-[[1-oxo-2-(1-piperidinyl)ethyl]amino]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(2,6-difluorophenyl)-[4-(5-fluoro-2-methyl-1-benzimidazolyl)-1-piperidinyl]methanone | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloro-N-[3-cyano-4-(phenylthio)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(4-chlorophenyl)-[4-[[(2,4-dichlorophenyl)thio]methyl]-4-hydroxy-1-piperidinyl]methanone | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-bromo-2,6-dimethylphenyl)-2-methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[(3,6-dichloro-2-methoxyphenyl)-oxomethyl]amino]benzoic acid propyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2,4-dichlorophenyl)-4-phenylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-butoxy-N-[4-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fm19g11 | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[(4,6-dimethyl-2-pyrimidinyl)sulfamoyl]phenyl]-2-nitrobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(2,5-dichlorophenoxy)methyl]-N-(2,6-dimethylphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[[(3-methyl-1-oxobutyl)amino]-sulfanylidenemethyl]amino]-N-phenylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetic acid [4-[[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]anilino]-oxomethyl]phenyl] ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[(4-tert-butylphenyl)-oxomethyl]amino]-3-methyl-2-sulfanylidene-5-thiazolecarboxylic acid ethyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methoxy-N-(2,3,4-trifluorophenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-phenylacetic acid [2-[4-[(4-ethoxyanilino)-oxomethyl]anilino]-2-oxoethyl] ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[(2-nitrophenyl)-oxomethyl]amino]benzoic acid propyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[oxo-(2,3,4,5,6-pentafluorophenyl)methyl]amino]benzoic acid ethyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-bromo-N-[3-(1-oxopentylamino)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(2,4-dichlorophenoxy)methyl]-N-[2-(dimethylamino)ethyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methoxy-N-[2-(3-methoxyphenoxy)ethyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(diethylsulfamoyl)phenyl]-4-(4-morpholinylmethyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,5-dimethyl-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[[[3-[(3-nitrophenyl)sulfamoyl]phenyl]-oxomethyl]amino]benzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-(3-methoxyphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloro-3-[(2,5-dimethylphenyl)sulfamoyl]-N-(2-phenylphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methyl-N-(2-phenylphenyl)-3-(phenylsulfamoyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[2-[[3-(1,3-benzoxazol-2-yl)anilino]-oxomethyl]phenyl]benzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dimethoxy-N-[4-(2,2,3,3-tetrafluoropropoxy)-3-(trifluoromethyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-azepanyl-[2-[4-(difluoromethylthio)anilino]phenyl]methanone | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[[(4-tert-butylphenyl)-oxomethyl]amino]-1H-1,2,4-triazole-5-carboxylic acid methyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-bromo-N-(4-ethylphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-amino-N-(2-methoxyphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(difluoromethoxy)-N-[5-[[4-(difluoromethylthio)phenyl]methyl]-2-thiazolyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(4-ethoxyphenyl)sulfonylamino]-N-[2-(4-morpholinyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(dimethylamino)-N-[2-(1,2,4-triazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2,5-dimethylphenyl)sulfonylamino]-N-[4-(2-pyrimidinylsulfamoyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(5-chloro-2-thiophenyl)sulfonylamino]-N-(2-methoxy-5-methylphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxy-N-[1-methyl-2-oxo-6-(trifluoromethyl)-3-pyridinyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-bromo-3-(trifluoromethyl)phenyl]-2,4,6-trimethylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methyl-N-[1-methyl-2-oxo-6-(trifluoromethyl)-3-pyridinyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[2-(4-fluoroanilino)-2-oxoethoxy]-3-methoxy-N-[4-(4-methoxyphenyl)-5-methyl-2-thiazolyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[3-[2-(2-carbamoylphenoxy)-1-oxoethyl]-2,5-dimethyl-1-pyrrolyl]propanoic acid methyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methyl-N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(dimethylsulfamoyl)-N-(diphenylmethyl)-2-(1-pyrrolidinyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(3-fluoro-4-methoxyphenyl)methoxy]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-chloro-2-methoxy-5-methylphenyl)-4-[(3,4-difluorophenyl)sulfonylamino]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[(3-methylphenyl)-oxomethyl]amino]benzoic acid (3,5-dimethyl-4-isoxazolyl)methyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(dimethylsulfamoyl)-N-(3-methylphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-chloro-2-(4-methyl-1-piperazinyl)phenyl]-3-(dimethylsulfamoyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methoxy-N-(4-methyl-2-thiazolyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(diethylsulfamoyl)-N-(3,5-dimethylphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dimethyl-N-[4-(4-methylpiperazino)benzyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(5-oxazolyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N1-(2,6-dimorpholino-3-pyridyl)-4-methylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-3,4-dimethylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sirtinol | | aldimine; benzamides; naphthols | anti-inflammatory agent; EC 3.5.1.98 (histone deacetylase) inhibitor; Sir2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[1-(3-methoxyphenyl)-3-(1-naphthalenylamino)-3-oxopropyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(1-naphthalenylamino)-3-oxo-1-phenylpropyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloro-3-(diethylsulfamoyl)-N-(2-nitrophenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4,5-trimethoxy-N-[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-methoxy-2-nitrophenyl)-3-[(2-methyl-1-oxopropyl)amino]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4,5-triethoxy-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[[4-[[2-(4-chloro-2-methylphenoxy)-1-oxopropyl]amino]phenyl]-oxomethyl]amino]benzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(5-chloro-2-hydroxyphenyl)-2-ethoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-[(2-furanylmethylamino)-oxomethyl]phenyl]-4-methyl-3-(1-piperidinylsulfonyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxy-N-[4-[1-[(4-methoxyanilino)-oxomethyl]cyclopentyl]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-chloro-2-(1-piperidinyl)phenyl]-4-(4-morpholinyl)-3-nitrobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(6-imidazo[2,1-b]thiazolyl)phenyl]-4-methoxy-3-(4-morpholinylsulfonyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
norcisapride | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prucalopride | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Dihydroalatamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxy-N-[2,2,2-trichloro-1-(4-methylanilino)ethyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-hydroxy-5-nitrophenyl)-3-nitrobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(1,3-benzothiazol-2-ylthio)-5-nitrophenyl]-2-fluorobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-[5-[(4-tert-butylphenyl)methylthio]-1,3,4-oxadiazol-2-yl]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-butan-2-yl-4-[4-oxo-3-(phenylmethyl)-2-thiazolidinyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[3-(2-furanylmethyl)-4-oxo-2-thiazolidinyl]-N-(3-propan-2-yloxypropyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methyl-N-[1-(4-prop-2-enyl-5-sulfanylidene-1H-1,2,4-triazol-3-yl)ethyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(4-methoxyphenyl)-2-thiazolyl]-N-(2-oxolanylmethyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-chloro-4-ethoxy-N-[3-(2-oxazolo[5,4-b]pyridinyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[(3-methoxyphenyl)-oxomethyl]amino]benzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[[oxo-[3-(1-piperidinylsulfonyl)phenyl]methyl]amino]benzoic acid | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-ethoxyphenyl)-2-(hydroxymethyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(5-acetyl-2-phenyl-4-sulfanylidene-1H-pyrimidin-6-yl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sb-224289 | | 1,2,4-oxadiazole; azaspiro compound; benzamides; organic heterotetracyclic compound | serotonergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(4-methylphenyl)methyl]-4-(1-pyrrolyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[(4-chlorophenyl)-oxomethyl]-N-[4-(1-piperidinylsulfonyl)phenyl]-3-piperidinecarboxamide | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-bromophenyl)-2-[(5,6-dimethyl-4-thieno[2,3-d]pyrimidinyl)thio]benzamide | | benzamides; thienopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(3,5-dimethyl-1-pyrazolyl)-N-[2-methoxy-5-(4-morpholinylsulfonyl)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-ethyl-3-[(4-fluorophenyl)-(4-morpholinyl)methyl]-2-thiophenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-cycloheptyl-4-(2-oxolanylmethoxy)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-methoxyphenyl)acetic acid [2-[4-[(4-ethoxyanilino)-oxomethyl]anilino]-2-oxoethyl] ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methyl-3-nitro-N-[4-[[(1-oxopropylamino)-sulfanylidenemethyl]amino]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(3-methyl-1-oxobutyl)-3-oxo-1,2,4-thiadiazol-5-yl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[4-[[(3-chlorophenyl)-oxomethyl]amino]phenyl]propanedioic acid dimethyl ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3,5-dimethylphenyl)-2-(2-nitroethyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[[(4-tert-butylphenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-[(4-ethoxyphenyl)-[4-(2-hydroxyethyl)-1-piperazinyl]methyl]-4,5-dimethyl-2-thiophenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxy-N-(5-phenyl-1,2,4-thiadiazol-3-yl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-chlorophenyl)-4-fluoro-3-(thiophen-2-ylmethylsulfamoyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-acetamido-N-[(4-ethoxy-3-methoxyphenyl)methyl]-4-[(4-methylphenyl)thio]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(4-morpholinylsulfonyl)phenyl]-4-(2-oxo-1-pyrrolidinyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N,N-dimethylsulfamic acid [3-[(4-methoxyanilino)-oxomethyl]phenyl] ester | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[1-(benzenesulfonyl)-2,2-dichloroethenyl]-4-methylbenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-chloro-3-[(4-chlorophenyl)sulfamoyl]phenyl]-4-propan-2-yloxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide | | benzamides; benzodioxoles; imidazoles; pyridines | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-[(2-bromo-5-methylphenyl)sulfamoyl]-4-methoxyphenyl]-4-fluorobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2,5-diethoxy-4-(4-morpholinyl)phenyl]-4-[(3,5-dimethyl-4-isoxazolyl)methoxy]-3-methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methyl-N-[2-[(5-oxo-2,3-dihydrothiazolo[2,3-b]quinazolin-3-yl)methylthio]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-cyano-N-[4-thiophen-2-yl-5-(2,2,2-trifluoro-1-oxoethyl)-2-thiazolyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(1-azepanylsulfonyl)-N-[5-[(4-chlorophenyl)sulfamoyl]-2-hydroxyphenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(4-fluorophenyl)-2-thiazolyl]-3-methoxy-4-[2-(4-morpholinyl)-2-oxoethoxy]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-chloro-3-(4-morpholinylsulfonyl)phenyl]-4-(2-oxolanylmethoxy)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-[(4-chlorophenyl)methylthio]-1H-1,2,4-triazol-5-yl]-4-cyanobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-methylphenoxy)-N-[2-[oxo(1-piperidinyl)methyl]phenyl]acetamide | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
imd 0354 | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-chlorophenyl)-3-[ethyl(phenyl)sulfamoyl]-4-fluorobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-tert-butyl-N-[3-[4-[3-[[(4-tert-butylphenyl)-oxomethyl]amino]propyl]-1-piperazinyl]propyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-nitro-4-[(6-nitro-4-quinolinyl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-amino-5-chloro-N-[(3R,4S)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tiapridex | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[2-methoxy-5-[[4-(4-methylphenyl)-1-phthalazinyl]amino]phenyl]-(1-piperidinyl)methanone | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
axitinib | | aryl sulfide; benzamides; indazoles; pyridines | antineoplastic agent; tyrosine kinase inhibitor; vascular endothelial growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)methyl]-N-(3-ethylphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
LSM-32377 | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ispinesib | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fk 866 | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[4-[[4-(1-benzothiophen-2-yl)-2-pyrimidinyl]amino]phenyl]-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
midostaurin | | benzamides; gamma-lactam; indolocarbazole; organic heterooctacyclic compound | antineoplastic agent; EC 2.7.11.13 (protein kinase C) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bms201038 | | (trifluoromethyl)benzenes; benzamides; fluorenes; piperidines | anticholesteremic drug; MTP inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mocetinostat | | aminopyrimidine; benzamides; pyridines; secondary amino compound; secondary carboxamide; substituted aniline | antineoplastic agent; apoptosis inducer; autophagy inducer; cardioprotective agent; EC 3.5.1.98 (histone deacetylase) inhibitor; hepatotoxic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cgp 74588 | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zm 447439 | | aromatic ether; benzamides; morpholines; polyether; quinazolines; secondary amino compound; tertiary amino compound | antineoplastic agent; apoptosis inducer; Aurora kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tak-715 | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
masitinib | | 1,3-thiazoles; benzamides; N-alkylpiperazine; pyridines | antineoplastic agent; antirheumatic drug; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide | | 1,3,4-oxadiazoles; benzamides; biphenyls; nitrile | EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
betrixaban | | benzamides; guanidines; monochloropyridine; monomethoxybenzene; secondary carboxamide | anticoagulant; EC 3.4.21.6 (coagulation factor Xa) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nigerloxin | | aromatic ether; benzamides; benzoic acids; phenols; styrenes | antioxidant; Aspergillus metabolite; EC 1.1.1.21 (aldehyde reductase) inhibitor; lipoxygenase inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
myxochelin b | | benzamides; catechols | bacterial metabolite; siderophore | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluopicolide | | benzamide fungicide; benzamides; dichlorobenzene; monochloropyridine; organofluorine compound | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eluxadoline | | amino acid amide; benzamides; imidazoles; L-phenylalanine derivative; methoxybenzoic acid | delta-opioid receptor antagonist; gastrointestinal drug; kappa-opioid receptor agonist; mu-opioid receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(2-tert-butylphenyl)sulfonylphenyl]-2,3,4-trihydroxy-5-[(2-propan-2-ylphenyl)methyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-[[5-[(4-acetyl-1-piperazinyl)-oxomethyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[(3,3-dimethylbutan-2-ylamino)methyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chir 090 | | acetylenic compound; benzamides; hydroxamic acid; L-threonine derivative; morpholines | antimicrobial agent; EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitor; lipopolysaccharide biosynthesis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ki11502 | | aromatic ether; benzamides; quinolines; thioureas | antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
az-628 | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
at 13387 | | benzamides; isoindoles; N-alkylpiperazine; resorcinols; tertiary carboxamide | antineoplastic agent; Hsp90 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[[2-(cyclohexylamino)-3,4-dioxo-1-cyclobutenyl]amino]methyl]-N-(4-ethoxyphenyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chidamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3,5-dichlorophenyl)-4-[(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)methyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mdv 3100 | | (trifluoromethyl)benzenes; benzamides; imidazolidinone; monofluorobenzenes; nitrile; thiocarbonyl compound | androgen antagonist; antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-nitro-4-(2-oxolanylmethylamino)-N-(2-phenylethyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-({2-[(3-hydroxyphenyl)amino]pyrimidin-4-yl}amino)benzamide | | aminopyrimidine; benzamides | protein kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azd 7545 | | benzamides; monochlorobenzenes; organofluorine compound; secondary carboxamide; sulfone; tertiary alcohol; tertiary carboxamide | EC 2.7.11.2 - [pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitor; hypoglycemic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-[2-(4-chloroanilino)-4-thiazolyl]phenyl]-3-(trifluoromethyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(trifluoromethyl)-N-[4-[2-[3-(trifluoromethyl)anilino]-4-thiazolyl]phenyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-5-oxazolecarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-4-thiazolecarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-4-pyridinecarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(4-bromophenyl)-N-[5-[[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)anilino]-oxomethyl]-2-methylphenyl]-1H-pyrazole-5-carboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-amino-1-[4-[2-(4-methoxyphenyl)ethylamino]-3-nitrophenyl]-3-oxopropyl]-4-bromobenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nvp-bhg712 | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
respirantin | | benzamides; cyclodepsipeptide; formamides; phenols | antimicrobial agent; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-[[5-[(4-acetyl-1-piperazinyl)-oxomethyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[(3-methylbutan-2-ylamino)methyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ph 797804 | | aromatic ether; benzamides; organobromine compound; organofluorine compound; pyridone | anti-inflammatory agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lde225 | | aminopyridine; aromatic ether; benzamides; biphenyls; morpholines; organofluorine compound; tertiary amino compound | antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gdc 0449 | | benzamides; monochlorobenzenes; pyridines; sulfone | antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist; teratogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[[1-[1-(methylthio)propan-2-yl]-4-piperidinyl]oxy]-N-(2-pyridinylmethyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[[1-(dimethylsulfamoyl)-4-piperidinyl]oxy]-N-[(3-methyl-5-isoxazolyl)methyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ponatinib | | (trifluoromethyl)benzenes; acetylenic compound; benzamides; imidazopyridazine; N-methylpiperazine | antineoplastic agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamide | | benzamides; biphenyls; cyclopropanes; dicarboxylic acid diamide | EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-tert-butyl-N-[5-[[2-oxo-2-(2-oxolanylmethylamino)ethyl]thio]-1,3,4-thiadiazol-2-yl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-ethoxy-N-[5-[[2-oxo-2-(2-oxolanylmethylamino)ethyl]thio]-1,3,4-thiadiazol-2-yl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
GRL-0617 | | benzamides; naphthalenes; secondary carboxamide; substituted aniline | anticoronaviral agent; protease inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide | | aminopyrimidine; benzamides; morpholines; nitrile; secondary amino compound; tertiary amino compound | anti-anaemic agent; antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2,6-difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonyl-1-piperazinyl)-1-piperidinyl]anilino]-4-pyrimidinyl]-2-imidazo[1,2-a]pyridinyl]-2-methoxybenzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
entrectinib | | benzamides; difluorobenzene; indazoles; N-methylpiperazine; oxanes; secondary amino compound; secondary carboxamide | antibacterial agent; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ixazomib | | benzamides; boronic acids; dichlorobenzene; glycine derivative | antineoplastic agent; apoptosis inducer; drug metabolite; orphan drug; proteasome inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-chlorophenyl)-4-[[2-[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]anilino]-5-fluoro-4-pyrimidinyl]amino]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-(2-thiazolyl)benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-aminophenyl)-4-[[[(2S,3S)-10-[[cyclohexyl(oxo)methyl]amino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
KOM70144 | | acetamides; benzamides; naphthalenes; secondary carboxamide | anticoronaviral agent; protease inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
iwr-1 endo | | benzamides; bridged compound; dicarboximide; quinolines | axin stabilizer; Wnt signalling inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ulixacaltamide | | benzamides; monochlorobenzenes; monofluorobenzenes; piperidines; secondary carboxamide | non-narcotic analgesic; T-type calcium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xl765 | | aromatic amine; aromatic ether; benzamides; quinoxaline derivative; sulfonamide | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azd4547 | | benzamides; N-arylpiperazine; pyrazoles | fibroblast growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2-propenamide | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
entecavir | | benzamides; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acp-196 | | aromatic amine; benzamides; imidazopyrazine; pyridines; pyrrolidinecarboxamide; secondary carboxamide; tertiary carboxamide; ynone | antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pf-06463922 | | aminopyridine; aromatic ether; azamacrocycle; benzamides; cyclic ether; monofluorobenzenes; nitrile; organic heterotetracyclic compound; pyrazoles | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
DDR1-IN-1 | | (trifluoromethyl)benzenes; aromatic ether; benzamides; N-alkylpiperazine; oxindoles; secondary carboxamide | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-methyl-5-[oxo-[3-(1-oxoprop-2-enylamino)-5-(trifluoromethyl)anilino]methyl]phenyl]-5-isoxazolecarboxamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
PF-06446846 | | benzamides; monochloropyridine; piperidines; tertiary carboxamide; triazolopyridine | antilipemic drug; EC 3.4.21.61 (kexin) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5,10-methylenetetrahydrofolic acid | | benzamides; methylenetetrahydrofolic acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-cyclohexyl-3-methyl-N-[(4-oxo-1H-quinazolin-2-yl)methyl]benzamide | | benzamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |